European Medicines Agency accepts marketing application of Biocon, Mylan product Industry-The Economic Times — November 3, 2016 comments off Mylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients.
Mylan and Biocon, which have co-developed insulin glargine, look forward to offering another insulin treatment option for diabetic patients.